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The Editor, Central venous catheter (CVC) placement is a common procedure done in the practice of anesthesia and critical care medicine for several indications. The right internal jugular vein (IJV) is usually preferred as it has a straight course and has less tendency for thrombosis and venous stenosis. [1] Arrhythmias on negotiating a guidewire during CVC insertion is considered as a confirmatory sign of entering right atrium (RA) by many clinicians. Atrial and ventricular premature contractions are the most common however supraventricular tachycardia can also result when the guide wire touches atrioventricular node for a prolonged duration. [2] Electrocardiographic (ECG) guidance is also used for confirming correct entry of CVC into superior vena cava (SVC) and RA. However, it requires special equipment and Schummer et al. described that increase in P wave size need not always correspond with the entry into of guide wire into RA. Moreover, ECG guidance is also unable to distinguish between venous and arterial catheter placement. [3] CVC under ultrasound (US) guidance is considered standard of care. [4] The needle is introduced under US guidance using either an out of a plane or an oblique approach to puncture the vein in real time. Most clinicians remove the US probe once the vein is punctured. A guide wire is inserted, and the CVC is introduced in the vein after dilating the skin. A chest radiograph is used to confirm the position of catheter after the procedure. The incidence of CVC malposition can be up to 5.01%. [5] Malpositioned CVC have been found occupying arteries, mediastinum, pleura, pericardium, trachea, esophagus, and subarachnoid space. Once malposition is confirmed
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Letters to Editor on chest radiograph, the CVC is usually rewired redirected/repositioned over a guide wire with or without fluoroscopy. The process of repositioning not only adds to patient's discomfort and anxiety, it also delays further treatment for the patient. Repositioning can also compromise sterility.
In our practice, we include the supraclavicular area during sterile preparation and perform a scan of the area with the probe in caudal orientation once the guide wire is inserted. This way, one can follow the guide wire going down into SVC/RA. In case the wire is not visible, the probe is moved medially or laterally to trace the guide wire. Figure 1 shows a guide wire which was inserted through right IJV, and instead of going down it took a right turn to enter the right subclavian vein (SCV). This can be repositioned in the same sitting before inserting the CVC by withdrawing the guide wire in real time till the right turn vanishes [ Figure 2 ]. By rotating the guide wire, it is maneuvered in such a way that it goes down into SVC/RA. By following this technique, another procedure involving readjustment can be avoided. While cannulating the left IJV, the wire would be seen taking a right turn on US for entering the RA/SVC, and the guide wire should not be seen inside the left SCV in the supraclavicular area.
In conclusion, we suggest to use US not only for puncturing a central vein but also to ensure that the catheter enters the destined place instead of getting malpositioned.
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Adenosine in Cardiac Catheterization Suite: Complication Re-Visited!
The Editor, Authors present a case of unanticipated bronchospasm following administration of adenosine during fractional flow reserve (FFR) coronary angiography (CAG) in a patient without reactive airway disease. A 71-year-old male was posted for elective coronary FFR testing for assessment of borderline stenosis (~70%) in the left anterior descending coronary artery. Monitored anesthesia care was planned. He presented with Class II dyspnea and angina equivalent. The stress test was inconclusive. He was a chronic smoker and hypertensive. Other medical history was insignificant. Auscultation revealed bilateral equal air entry without any adventitious sounds and clinical features of obstructive airway disease. Routine investigations were normal. Two-dimensional transthoracic echocardiograms showed an ejection fraction of 50% with a Grade 1 diastolic dysfunction and no regional wall motion abnormality.
After regular CAG shoots, FFR testing was commenced using intravenous injection adenosine 140 mcg/kg/min for 3 min. Within few seconds, however, the patient complained of dyspnea and audible wheeze was noted. Recognizing adenosine induced bronchospasm, drug infusion was stopped, and inhaled salbutamol puffs followed by bronchodilator nebulization were administered. The patient responded to the treatment gradually, and sidestream capo gram too was normalized later on. There was no episode of desaturation as well. FFR test was switched to intravascular ultrasound and medical management was advised.
FFR estimates the functional impact of coronary artery stenosis; measures pressure difference and flow across it and helps in determining the need for angioplasty. A cut-off point of 0.75-0.80 has been proposed; anything less than it corresponds to inducible ischemia suitable for angioplasty, whereas higher values indicate a non-significant stenosis. [1] This test requires hyperemia in the vessel and intravenous adenosine is most commonly used for this purpose.
The half-life of adenosine is brief (<10 s); hence, its adverse effects are generally short-lived. Absolute contraindications to the use of adenosine infusion are known allergy and severe asthma. It can result in direct stimulation of pulmonary C fibers producing dyspnea. [1] Although life-threatening side effects are rare, it can trigger dyspnea and bronchospasm in patients with preexisting reactive airway disease, obstructive lung disease, even in an awake patient without concurrent respiratory disease. [2, 3] The adenoscan study reports 0.1% incidence of bronchospasm. There is no report of such complication, however, during FFR test. Alternatives to adenosine include nicorandil, papaverine, and newer selective adenosine A2a receptor agonist regadenoson with the similar hyperemic effect but without any additional side effects. [4, 5] Instantaneous wave-free ratio (i-FR) measures the ratio of distal coronary
